Mitchell P. Kopin 13D and 13G filings for Arcadia Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 08:04 am Purchase | 2021-12-31 | 13G | Arcadia Biosciences, Inc. RKDA | Mitchell P. Kopin | 26,464 4.600% | 7,831 (+42.03%) | Filing |
| 2021-01-29 07:06 am Purchase | 2020-12-31 | 13G | Arcadia Biosciences, Inc. RKDA | Mitchell P. Kopin | 18,633 5.300% | 2,986 (+19.09%) | Filing |
| 2020-02-11 06:37 am Purchase | 2019-12-31 | 13G | Arcadia Biosciences, Inc. RKDA | Mitchell P. Kopin | 15,647 6.800% | 6,323 (+67.81%) | Filing |